Anti-Money Laundering Compliance in Life Sciences

5/5
6
AML

Duration :

1

1 hour(s)

Skill level:

Regulatory

Language:

English

Final exam:

Yes

Certificate of Completion:

Yes

CEU / CPD Accreditation:

Yes

Certification:

Successful completion provides learners with a dated, traceable and downloadable certificate for the course : 

Each certificate is CPD/CEU accredited and 21 CFR PART 11 compliant. Certificates validity can be checked online through our certificate online checker. They can also be shared on Linkedin.

Description:

The life sciences industry operates within complex global supply chains and high-value transactions, making it vulnerable to money-laundering and financial-crime risks. Pharmaceutical, biotech, medical-device, and clinical research organizations must understand how Anti-Money Laundering (AML) requirements apply to their operations.

This course provides a practical overview of AML compliance in the life sciences industry. Learners will explore how global AML frameworks apply across the U.S., EU, and UK, and how effective AML programs are built and maintained.

By completing this course, you will gain the knowledge needed to identify AML risks, understand due-diligence and reporting expectations, and support compliant, ethical operations within regulated life-sciences environments.

Upon successful completion, you will receive a validated certificate accredited with CPD/CEU credits, suitable for audit and compliance documentation.

✅ Who should enroll?

  • Compliance, ethics, and financial-crime risk managers in life-sciences organizations
  • Finance, accounts payable, and procurement professionals managing high-risk payments
  • Supply-chain, sourcing, and third-party due-diligence teams
  • Regulatory affairs and internal audit professionals overseeing compliance programs
  • Professionals responsible for AML, sanctions screening, or anti-bribery controls

 

🎯 What you’ll learn?

  • Understand how money laundering risks impact life-sciences organizations
  • Identify AML red flags across payments, procurement, and clinical-trial activities
  • Learn how global AML frameworks apply in the U.S., EU, and UK
  • Apply customer due diligence (CDD/EDD) and sanctions screening requirements
  • Implement core AML controls within life-sciences compliance systems

 

Curriculum:

Lesson 1: Money Laundering and Its Relevance to Life Sciences

Lesson 2: Global and Regional AML Frameworks (FATF, EU, UK, U.S.)

Lesson 3: Customer Due Diligence (CDD), Enhanced Due Diligence (EDD), and Beneficial Ownership

Lesson 4: Payments, Sanctions, and Red Flags in Life-Sciences Transactions

Lesson 5: Building an AML Compliance Program for Life-Sciences Organizations

Lesson 6: Investigations, Reporting, and Regulatory Interaction

Conclusion

Assessment

Author:

marc
Marc Estrow
Marc Estrow is an Oxford University graduate from the department of pharmacology with over 20 years’ experience in drug safety & pharmacovigilance, who specializes in global safety compliance, business process improvement and signal detection. He has worked with over 50 clients in the US, France and United Kingdom. He is a featured speaker at conferences and webinars on drug safety topics including auditing and reporting.

Reviews:

5/5
6

$95

Buy now

  Large group ? Request a quote !

This course includes:
One-year access
Updated content every month
Certificate of completion

GxP-Training Benefits

[finale_countdown_timer campaign_id="40465" skip_rules= "yes"]

$95,00 / year

$95,00 / year

We might have this course but it's not displayed online. Please type your email and we will get back to you within 24h

No video yet for this course